CHF 0.84
(-6.44%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - CHF | -100.0% |
2022 | 18.39 Million CHF | 13.05% |
2021 | 16.26 Million CHF | 78.28% |
2020 | 9.12 Million CHF | 69.25% |
2019 | 5.39 Million CHF | 33.44% |
2018 | 4.04 Million CHF | -49.55% |
2017 | 8 Million CHF | 40.82% |
2016 | 5.68 Million CHF | 156.49% |
2015 | 2.21 Million CHF | 607.72% |
2014 | 313.3 Thousand CHF | 460.47% |
2013 | 55.9 Thousand CHF | -6.29% |
2012 | 59.65 Thousand CHF | 29.78% |
2011 | 45.96 Thousand CHF | -61.09% |
2010 | 118.11 Thousand CHF | 72.68% |
2009 | 68.4 Thousand CHF | 0.0% |
2008 | - CHF | 0.0% |
2007 | - CHF | 0.0% |
2006 | - CHF | 0.0% |
2005 | - CHF | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - CHF | 0.0% |
2023 FY | - CHF | -100.0% |
2023 Q4 | - CHF | 0.0% |
2023 Q2 | 15.88 Million CHF | 0.0% |
2022 Q4 | 18.39 Million CHF | 0.0% |
2022 Q2 | 20.61 Million CHF | 0.0% |
2022 FY | 18.39 Million CHF | 13.05% |
2021 Q4 | 16.26 Million CHF | 0.0% |
2021 Q2 | 9.88 Million CHF | 0.0% |
2021 FY | 16.26 Million CHF | 78.28% |
2020 FY | 9.12 Million CHF | 69.25% |
2020 Q2 | 7.05 Million CHF | 0.0% |
2020 Q4 | 9.12 Million CHF | 0.0% |
2019 Q2 | 5.32 Million CHF | 0.0% |
2019 FY | 5.39 Million CHF | 33.44% |
2019 Q4 | 5.39 Million CHF | 0.0% |
2018 Q2 | 6.4 Million CHF | 0.0% |
2018 Q4 | 4.04 Million CHF | 0.0% |
2018 FY | 4.04 Million CHF | -49.55% |
2017 FY | 8 Million CHF | 40.82% |
2017 Q4 | 8 Million CHF | 0.0% |
2017 Q2 | 7.2 Million CHF | 0.0% |
2016 Q4 | 5.68 Million CHF | 0.0% |
2016 Q2 | 3.5 Million CHF | 0.0% |
2016 FY | 5.68 Million CHF | 156.49% |
2015 Q4 | 2.21 Million CHF | 0.0% |
2015 FY | 2.21 Million CHF | 607.72% |
2015 Q2 | 73.4 Thousand CHF | 0.0% |
2014 FY | 313.3 Thousand CHF | 460.47% |
2014 Q2 | 65.9 Thousand CHF | 0.0% |
2014 Q4 | 313.3 Thousand CHF | 0.0% |
2013 Q4 | 55.9 Thousand CHF | 0.0% |
2013 Q2 | 61.2 Thousand CHF | 0.0% |
2013 FY | 55.9 Thousand CHF | -6.29% |
2012 Q2 | 60.26 Thousand CHF | 0.0% |
2012 Q4 | 59.65 Thousand CHF | 0.0% |
2012 FY | 59.65 Thousand CHF | 29.78% |
2011 Q4 | 45.96 Thousand CHF | 0.0% |
2011 FY | 45.96 Thousand CHF | -61.09% |
2011 Q2 | 71.78 Thousand CHF | 0.0% |
2010 Q2 | 134.37 Thousand CHF | 0.0% |
2010 FY | 118.11 Thousand CHF | 72.68% |
2010 Q4 | 118.11 Thousand CHF | 0.0% |
2009 Q4 | 68.4 Thousand CHF | 0.0% |
2009 FY | 68.4 Thousand CHF | 0.0% |
2008 FY | - CHF | 0.0% |
2007 FY | - CHF | 0.0% |
2006 FY | - CHF | 0.0% |
2005 FY | - CHF | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Addex Therapeutics Ltd | - CHF | NaN% |
BB Biotech AG | -2.63 Billion CHF | 100.0% |
Basilea Pharmaceutica AG | 26.41 Million CHF | 100.0% |
Idorsia Ltd | 59.14 Million CHF | 100.0% |
Kuros Biosciences AG | 4.85 Million CHF | 100.0% |
Molecular Partners AG | - CHF | NaN% |
Relief Therapeutics Holding AG | 557 Thousand CHF | 100.0% |
Santhera Pharmaceuticals Holding AG | 1.81 Million CHF | 100.0% |